AWM
CRBU icon

AE Wealth Management’s Caribou Biosciences CRBU Stock Holding History

AE Wealth Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Buy
+10,000
New +$19.8K ﹤0.01% 2282

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AE Wealth Management's CRBU Position: Q2 2026 in Review

AE Wealth Management opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 10,000 shares worth $17.6K. The stake represents ﹤0.01% of the portfolio and ranks #2282 among its holdings.

137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • AE Wealth Management held 10,000 shares of Caribou Biosciences worth $17.6K as of Q2 2026.
  • Caribou Biosciences was a new AE Wealth Management position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #2282 holding.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.